However, this is mainly a problem with the older CGM systems, which are not as accurate as the newer ones. It can become so bothersome-or embarrassing, depending on where you are or who you’re with-that they simply turn off the alarms altogether. Some people complain about the repeated alarms (real or false). Your diabetes care team, particularly your diabetes educator, can help you learn to use your device. However, the manufacturers offer online video tutorials to guide you through the process. This can get a little complicated, especially if you don’t read the instructions. To use the alarm and alert features, you have to program your settings, such as your low glucose threshold and target ranges. Plus, some are factory calibrated, eliminating the hassle and pain of calibrating with finger sticks. While not all real-time CGMs offer this benefit, some allow you to make treatment decisions-how much insulin to dose, for instance-without the need for finger-stick confirmation. For example, if you don’t wake up to a low glucose alarm during the night, someone else will be alerted and can get in touch with you. It acts as a safety net, especially when traveling. The ability to share data with family members and friends is another important feature. With real-time CGM devices, data is constantly pushed to a receiver or smartphone without the need for additional action, such as a finger prick. This allows time for adjustments that could lessen the impact of high or low blood sugar or avoid it altogether. The most significant benefit of all real-time CGM systems is having audible alarms that can warn you if your blood sugar (blood glucose) is getting too high. Over one year, I will complete three discrete studies to address my research question.These systems are made up of three components: the sensor (a small wire catheter that is inserted under the skin on your arm or abdomen), a transmitter that attaches to the sensor, and a handheld receiver and/or smartphone that displays your glucose data in real time. I aim to generate scientific evidence to tailor support and resources for effective CGM use in older adults with T1D. “My overarching hypothesis is that delivering CGM to older adults with T1D demands new approaches that consider a breadth of different individual-level needs for patient-oriented ‘onboarding’ and use in daily life. However, not all older adults use CGM right now. The findings of that study suggested that CGM may offer life-saving benefits for older adults. In a study of older adults, in which half of the participants were randomized to use CGM for six months, CGM reduced hypoglycemia. Compared to self-monitoring with intermittent finger sticks and a glucometer, CGM offers greater insight into current glucose levels and trends, in addition to notifications for out-of-range readings and alarms for low glucose levels. Thus, much of diabetes care and management in older adulthood is focused around avoiding these dangerous episodes of hypoglycemia.ĬGM is a new, technologic approach to glucose monitoring that transmits real-time or near real-time glucose readings from an on-body sensor to a small device. As individuals age, both the risk for and the danger of low blood sugar (i.e. There is a growing population of older adults (defined as adults who are 65 years of age or older) with T1D. With $50K in funding from the Diabetics Research Connection, early career researcher and Assistant Professor of Nutrition Anna Kahkoska, MD, PhD, will study a new approach to continuous glucose monitoring (CGM) that could be especially helpful for older adults with Type 1 diabetes (T1D). Khakoska receives funding to study new approach to T1D glucose monitoring The award winner will be awarded $5,000 and be invited to give a presentation at the Annual Meeting. In particular, he is interested in infectious diseases, primarily HIV and birth outcomes.” These study designs include randomized experiments and observational studies. “He is interested in study designs and analyses that accurately estimate parameters of central interest to population-health scientists. Cole works to build robust, accurate, and impactful knowledge at the intersection of epidemiology and statistics,” SER stated. The prestigious Marshall Joffe Epidemiologic Methods Research Award is given annually to recognize outstanding accomplishments in developing, adapting, or translating a methodological concept or approach whose usefulness has been demonstrated through fruitful adoption in epidemiology, including applied population health research settings. Stephen Cole, PhD, professor of epidemiology, has received the 2022 Marshall Joffe Epidemiologic Methods Research Award from the Society for Epidemiologic Research (SER).
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |